How much funding has Akili raised?

Akili has raised $178.0M in total funding, most recently a series d round.

Who are Akili's investors?

Akili's investors include Polaris Partners, Temasek, Social Capital Hedosophia, Neuberger Berman Funds, Baillie Gifford, Amgen.

Where is Akili headquartered?

Akili is headquartered in Boston, Massachusetts, United States.

What industry is Akili in?

Akili operates in Biotech, Healthcare.

Akili

IPO

Akili Interactive

Boston, United States · Founded 2011 · $178.0M raised

Biotech

Healthcare

Headquarters: Boston, Massachusetts
Employees: 51–200
Founded: 2011
Business Model: B2C

Website: akiliinteractive.com
Total Funding: $178.0M
Last Round: $110.0M Series DApr 2021
Rounds: 7

About

Akili Interactive is a digital therapeutics company creating a new class of cognitive medicines delivered through engaging video game experiences. Its flagship products, EndeavorRx (FDA-authorized for children with ADHD) and EndeavorOTC (clinically proven for adults with ADHD), combine neuroscience with proprietary game-based technology to improve attention and focus.

Summary

Akili is a Biotech company based in Boston, United States, founded in 2011. It has raised $178.0M in total across 7 rounds, most recently a $110.0M Series D round in Apr 2021. Investors include Polaris Partners, Temasek and Social Capital Hedosophia.

LinkedIn X (Twitter)